Cargando…
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
SIMPLE SUMMARY: Despite great advances in cancer therapy, tumor heterogeneity continues to be a great barrier for the successful treatment of cancer. It has long been established that tumor heterogeneity is prevelant in most cancer patients and is a major driver of acquired resistance to all forms o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918981/ https://www.ncbi.nlm.nih.gov/pubmed/33671881 http://dx.doi.org/10.3390/cancers13040806 |